RSNA: GE highlights cornucopia of imaging technology

GE Healthcare (Booth 4029) is highlighting technologies in a variety of modalities--including MR, ultrasound and CT imaging--at the 2009 Radiological Society of North America (RSNA) conference in Chicago.

On display will be the Venue 40compact ultrasound system, which the company said provides rapid diagnostics and visualization of needle guidance for procedures in real-time at the bedside. GE said that clinicians also could use this device to help diagnose and monitor a patient with rheumatoid arthritis for medication injections, and help detect abnormalities in a trauma patient.

GE also will feature its Optima MR450w, a new 70cm, 1.5T MR system that features a 50cm field-of-view. OpTix, an optical radiofrequency (RF) system, uses the MR signal for crisp images and anatomy-optimized RF coils provide external coverage where needed. The system is clinically optimized for specific anatomies, including breast imaging capabilities, and can accommodate more patients with fewer scans, according to the firm.

GE also is highlighting its Discovery CT750 HD, a CT platform with the new Gemstone CT scintillator material and Gemstone Spectral Imaging (GSI). According to the company, the Discovery CT750 HD utilizes Adaptive Statistical Iterative Reconstruction (ASIR) imaging technology.




Around the web

Harvard’s David A. Rosman, MD, MBA, explains how moving imaging outside of hospitals could save billions of dollars for U.S. healthcare.

Back in September, the FDA approved GE HealthCare’s new PET radiotracer, flurpiridaz F-18, for patients with known or suspected CAD. It is seen by many in the industry as a major step forward in patient care. 

After three years of intermittent shortages of nuclear imaging tracer technetium-99m pyrophosphate, there are no signs of the shortage abating.